New partnership boosts entrepreneurship on SUND’s pharmaceutical programmes – University of Copenhagen

Health > News > News 2016 > New partnership boosts...

20 October 2016

New partnership boosts entrepreneurship on SUND’s pharmaceutical programmes


SUND has just entered into a strategic partnership with the biopharmaceutical company Bristol-Myers Squibb and the Danish Foundation for Entrepreneurship. The new partnership, which aims to build a long-term partnership, will initially offer master’s students at SUND’s PharmaSchool new courses and competencies in entrepreneurship and innovation.

SUND’s pharmaceutical students will be able to do the new entrepreneurship course already from autumn 2017, when the pharmaceutical company Bristol-Myers Squibb makes Danish and international experts available as lecturers in innovation, business strategy, development of pharmaceutical products etc. Bristol-Myers Squibb will also award two start-up grants of DKK 50,000 each to the two students presenting projects with the greatest potential within the biopharmaceutical area.

“The extensive investments made by Bristol-Myers Squibb in Denmark have led to greater expertise in Danish biotech and the challenges that many talented researchers are facing when they decide to become an entrepreneur. This has prompted us to support this discipline, which will hopefully also strengthen the relations between the academic world and the corporate sector,” says Anders Thelborg, Country Manager, Denmark, of Bristol-Myers Squibb.

In recent years, Bristol-Myers Squibb has invested more than DKK 10 billion in Danish research and development projects. Anders Thelborg is part of the Danish government’s growth team, which is to contribute to the development of the life sciences field in Denmark. 

The Faculty of Health and Medical Sciences at Panum, which formed the venue for the dialogue when three ministers, the government’s growth team and a large number of key players recently met to discuss how Denmark can ensure continued growth in and increased exports of pharmaceutical and medical products. In this context, both the corporate sector, NGOs and research institutions pointed out the need for increased cooperation, recruitment and talent development.

“I’m very pleased that Bristol-Myers Squibb has put action behind their intentions in record time. We would be happy to extend our collaboration with the corporate sector and ensure that our talented graduates have precisely the competencies demanded in many key positions, both in Denmark and abroad,” says Dean Ulla Wewer from the Faculty of Health and Medical Sciences.

“With this new partnership, we ensure that the students’ academic knowledge is combined with entrepreneurial skills. This means that, in future, they will be able to act on the basis of insights and opportunities, as well as creating innovation within the biopharmaceutical industry. We have high expectations of the partnership,” says Christian Vintergaard, Managing Director of the Danish Foundation for Entrepreneurship.

Read more in the article in the Danish newspaper Berlingske Business published Monday, 17 October 2016.